SP03. Rethinking the Use of Anticholinergics in Older Adults Diagnosed with Tardive Dyskinesia

Tune in as Jennifer Mondillo, a gerontology nurse practitioner, and Rob Leffler, a board-certified geriatric pharmacist, explain the inappropriate use of anticholinergic medications to treat older adults with tardive dyskinesia (TD), a drug-induced movement disorder. These experts emphasize the importance of reducing or eliminating the anticholinergic burden in patients with TD and discuss practical approaches to evaluating anticholinergic use in LTC residents with drug-induced movement disorders, de-prescribing, and treating TD appropriately with VMAT2 inhibitors. This podcast was sponsored and co-developed by Neurocrine Biosciences, Inc.” This podcast is an educational program sponsored and co-developed by Neurocrine Biosciences.Neurocrine Biosciences is a pioneering company with over 30 years of experience dedicated to discovering and developing life-changing treatments for neurological, neuroendocrine, and neuropsychiatric disorders. Learn more: https://www.neurocrine.com/Discover GAPNA: https://www.gapna.org/Production management by Anthony J. Jannetti, Inc., for the Gerontological Advanced Practice Nurses Association.Opening Music by:Optimistic / Inspirational by Mixaund | https://mixaund.bandcamp.com
Music promoted by https://www.free-stock-music.comClosing Music by:Scott Holmes.http://www.scottholmesmusic.com